Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily

J. Christopher Gorski, Stephen D. Hall, David R. Jones, Mark VandenBranden

Research output: Contribution to journalArticle

351 Citations (Scopus)

Abstract

The capabilities of cytochrome P4503A4 (CYP3A4), CYP3A5, and fetal hepatic microsomes containing CYP3A7 to metabolize midazolam were investigated using human hepatic microsomes and purified CYP3A4 and CYP3A5. Under initial rate conditions and high substrate concentration (400 μM midazolam), variability among eighteen human liver microsomal samples was 30- and 16- fold for 1′- and 4-hydroxylation of midazolam, respectively. Exclusion of two samples isolated from patients previously administered barbiturates reduced the inter-individual variability to 10.5- and 6.0-fold for 1′- and 4-hydroxylation, respectively. Six fetal hepatic microsomal samples showed 10-fold variation in both 1′-hydroxymidazolam and 4-hydroxymidazolam formation rates. The rates of formation of 4-hydroxymidazolam and 1′-hydroxymidazolam from midazolam by adult samples containing only CYP3A4 and by fetal liver samples were highly correlated (r2=0.99 and 0.97, P< 0.01, respectively). The rates of formation of 1′-hydroxymidazolam and 4-hydroxymidazolam from midazolam (400 μM) by adult samples that contained only CYP3A4 were correlated significantly (P < 0.01) with the ability of the samples to N-demethylate erythromycin (r2=0.95 and 0.92, respectively), 6β-hydroxylate testosterone (r2=0.96 and 0.96, respectively), and the CYP3A4 content of the samples (r2=0.89 and 0.86, respectively). Microsomal samples containing CYP3A5 in addition to CYP3A4 exhibited a significantly greater ration of 1′-hydroxymidazolam to 4-hydroxymidazolan compared with samples containing only CYP3A4 or CYP3A7 (P < 0.001). Purified CYP3A5 in a reconstituted system, consisting of dilauroylphosphatidylcholine, cytochrome b5, and NADPH-cytochrome P450 reductase, and an NADPH-regenerating system displayed a 2-fold greater rate of 1′-hydroxymidazolam formation and a similar rate of 4-hydroxymidazolam formation compared with a reconstituted system with CYP3A4. In conclusion, CYP3A4, CYP3A5, and fetal microsomes containing CYP3A7 catalyze 1′- and 4-hydroxylation of midazolam with the ratio of these metabolites indicative of the CYP3A form.

Original languageEnglish (US)
Pages (from-to)1643-1653
Number of pages11
JournalBiochemical Pharmacology
Volume47
Issue number9
DOIs
StatePublished - Apr 29 1994

Fingerprint

Cytochrome P-450 CYP3A
Midazolam
Cytochromes
Biotransformation
Hydroxylation
Microsomes
Liver
Cytochromes b5
NADPH-Ferrihemoprotein Reductase
Barbiturates
Erythromycin
Metabolites
NADP
Testosterone
1-hydroxymethylmidazolam
4-hydroxymidazolam

Keywords

  • CYP3A subfamily
  • cytochrome P450
  • human liver microsomes
  • hydroxylation
  • midazolam
  • regioselective

ASJC Scopus subject areas

  • Pharmacology

Cite this

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. / Christopher Gorski, J.; Hall, Stephen D.; Jones, David R.; VandenBranden, Mark.

In: Biochemical Pharmacology, Vol. 47, No. 9, 29.04.1994, p. 1643-1653.

Research output: Contribution to journalArticle

Christopher Gorski, J. ; Hall, Stephen D. ; Jones, David R. ; VandenBranden, Mark. / Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. In: Biochemical Pharmacology. 1994 ; Vol. 47, No. 9. pp. 1643-1653.
@article{61cfb32842d5482da8fef8fb6953fa2c,
title = "Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily",
abstract = "The capabilities of cytochrome P4503A4 (CYP3A4), CYP3A5, and fetal hepatic microsomes containing CYP3A7 to metabolize midazolam were investigated using human hepatic microsomes and purified CYP3A4 and CYP3A5. Under initial rate conditions and high substrate concentration (400 μM midazolam), variability among eighteen human liver microsomal samples was 30- and 16- fold for 1′- and 4-hydroxylation of midazolam, respectively. Exclusion of two samples isolated from patients previously administered barbiturates reduced the inter-individual variability to 10.5- and 6.0-fold for 1′- and 4-hydroxylation, respectively. Six fetal hepatic microsomal samples showed 10-fold variation in both 1′-hydroxymidazolam and 4-hydroxymidazolam formation rates. The rates of formation of 4-hydroxymidazolam and 1′-hydroxymidazolam from midazolam by adult samples containing only CYP3A4 and by fetal liver samples were highly correlated (r2=0.99 and 0.97, P< 0.01, respectively). The rates of formation of 1′-hydroxymidazolam and 4-hydroxymidazolam from midazolam (400 μM) by adult samples that contained only CYP3A4 were correlated significantly (P < 0.01) with the ability of the samples to N-demethylate erythromycin (r2=0.95 and 0.92, respectively), 6β-hydroxylate testosterone (r2=0.96 and 0.96, respectively), and the CYP3A4 content of the samples (r2=0.89 and 0.86, respectively). Microsomal samples containing CYP3A5 in addition to CYP3A4 exhibited a significantly greater ration of 1′-hydroxymidazolam to 4-hydroxymidazolan compared with samples containing only CYP3A4 or CYP3A7 (P < 0.001). Purified CYP3A5 in a reconstituted system, consisting of dilauroylphosphatidylcholine, cytochrome b5, and NADPH-cytochrome P450 reductase, and an NADPH-regenerating system displayed a 2-fold greater rate of 1′-hydroxymidazolam formation and a similar rate of 4-hydroxymidazolam formation compared with a reconstituted system with CYP3A4. In conclusion, CYP3A4, CYP3A5, and fetal microsomes containing CYP3A7 catalyze 1′- and 4-hydroxylation of midazolam with the ratio of these metabolites indicative of the CYP3A form.",
keywords = "CYP3A subfamily, cytochrome P450, human liver microsomes, hydroxylation, midazolam, regioselective",
author = "{Christopher Gorski}, J. and Hall, {Stephen D.} and Jones, {David R.} and Mark VandenBranden",
year = "1994",
month = "4",
day = "29",
doi = "10.1016/0006-2952(94)90543-6",
language = "English (US)",
volume = "47",
pages = "1643--1653",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily

AU - Christopher Gorski, J.

AU - Hall, Stephen D.

AU - Jones, David R.

AU - VandenBranden, Mark

PY - 1994/4/29

Y1 - 1994/4/29

N2 - The capabilities of cytochrome P4503A4 (CYP3A4), CYP3A5, and fetal hepatic microsomes containing CYP3A7 to metabolize midazolam were investigated using human hepatic microsomes and purified CYP3A4 and CYP3A5. Under initial rate conditions and high substrate concentration (400 μM midazolam), variability among eighteen human liver microsomal samples was 30- and 16- fold for 1′- and 4-hydroxylation of midazolam, respectively. Exclusion of two samples isolated from patients previously administered barbiturates reduced the inter-individual variability to 10.5- and 6.0-fold for 1′- and 4-hydroxylation, respectively. Six fetal hepatic microsomal samples showed 10-fold variation in both 1′-hydroxymidazolam and 4-hydroxymidazolam formation rates. The rates of formation of 4-hydroxymidazolam and 1′-hydroxymidazolam from midazolam by adult samples containing only CYP3A4 and by fetal liver samples were highly correlated (r2=0.99 and 0.97, P< 0.01, respectively). The rates of formation of 1′-hydroxymidazolam and 4-hydroxymidazolam from midazolam (400 μM) by adult samples that contained only CYP3A4 were correlated significantly (P < 0.01) with the ability of the samples to N-demethylate erythromycin (r2=0.95 and 0.92, respectively), 6β-hydroxylate testosterone (r2=0.96 and 0.96, respectively), and the CYP3A4 content of the samples (r2=0.89 and 0.86, respectively). Microsomal samples containing CYP3A5 in addition to CYP3A4 exhibited a significantly greater ration of 1′-hydroxymidazolam to 4-hydroxymidazolan compared with samples containing only CYP3A4 or CYP3A7 (P < 0.001). Purified CYP3A5 in a reconstituted system, consisting of dilauroylphosphatidylcholine, cytochrome b5, and NADPH-cytochrome P450 reductase, and an NADPH-regenerating system displayed a 2-fold greater rate of 1′-hydroxymidazolam formation and a similar rate of 4-hydroxymidazolam formation compared with a reconstituted system with CYP3A4. In conclusion, CYP3A4, CYP3A5, and fetal microsomes containing CYP3A7 catalyze 1′- and 4-hydroxylation of midazolam with the ratio of these metabolites indicative of the CYP3A form.

AB - The capabilities of cytochrome P4503A4 (CYP3A4), CYP3A5, and fetal hepatic microsomes containing CYP3A7 to metabolize midazolam were investigated using human hepatic microsomes and purified CYP3A4 and CYP3A5. Under initial rate conditions and high substrate concentration (400 μM midazolam), variability among eighteen human liver microsomal samples was 30- and 16- fold for 1′- and 4-hydroxylation of midazolam, respectively. Exclusion of two samples isolated from patients previously administered barbiturates reduced the inter-individual variability to 10.5- and 6.0-fold for 1′- and 4-hydroxylation, respectively. Six fetal hepatic microsomal samples showed 10-fold variation in both 1′-hydroxymidazolam and 4-hydroxymidazolam formation rates. The rates of formation of 4-hydroxymidazolam and 1′-hydroxymidazolam from midazolam by adult samples containing only CYP3A4 and by fetal liver samples were highly correlated (r2=0.99 and 0.97, P< 0.01, respectively). The rates of formation of 1′-hydroxymidazolam and 4-hydroxymidazolam from midazolam (400 μM) by adult samples that contained only CYP3A4 were correlated significantly (P < 0.01) with the ability of the samples to N-demethylate erythromycin (r2=0.95 and 0.92, respectively), 6β-hydroxylate testosterone (r2=0.96 and 0.96, respectively), and the CYP3A4 content of the samples (r2=0.89 and 0.86, respectively). Microsomal samples containing CYP3A5 in addition to CYP3A4 exhibited a significantly greater ration of 1′-hydroxymidazolam to 4-hydroxymidazolan compared with samples containing only CYP3A4 or CYP3A7 (P < 0.001). Purified CYP3A5 in a reconstituted system, consisting of dilauroylphosphatidylcholine, cytochrome b5, and NADPH-cytochrome P450 reductase, and an NADPH-regenerating system displayed a 2-fold greater rate of 1′-hydroxymidazolam formation and a similar rate of 4-hydroxymidazolam formation compared with a reconstituted system with CYP3A4. In conclusion, CYP3A4, CYP3A5, and fetal microsomes containing CYP3A7 catalyze 1′- and 4-hydroxylation of midazolam with the ratio of these metabolites indicative of the CYP3A form.

KW - CYP3A subfamily

KW - cytochrome P450

KW - human liver microsomes

KW - hydroxylation

KW - midazolam

KW - regioselective

UR - http://www.scopus.com/inward/record.url?scp=0028234586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028234586&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(94)90543-6

DO - 10.1016/0006-2952(94)90543-6

M3 - Article

C2 - 8185679

AN - SCOPUS:0028234586

VL - 47

SP - 1643

EP - 1653

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 9

ER -